Celltrion (068270.KS) is joining forces with the Kobe Biomedical Innovation Cluster (KBIC), Japan’s largest biocluster, to identify promising biotech startups. The plan is to combine Japan’s strength in basic research with Celltrion’s experience in drug development and global commercialization, extending the partnership toward securing next-generation pipeline assets.
